SARS-CoV-2 versus Influenza A Virus: Characteristics and Co-Treatments

被引:3
|
作者
Wang, Xinyi [1 ]
Li, Jingwen [1 ]
Liu, Hanshu [1 ]
Hu, Xinyu [1 ]
Lin, Zhicheng [2 ]
Xiong, Nian [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430000, Peoples R China
[2] Harvard Med Sch, Mclean Hosp, Belmont, MA 02478 USA
基金
中国国家自然科学基金;
关键词
SARS-CoV-2; influenza A; co-treatments; variants; smoking and alcohol use; ALCOHOL-USE; COVID-19; LOCKDOWN; T-CELLS; INNATE; RESPONSES; SMOKING; CONSUMPTION; VACCINATION; MECHANISMS; DIAGNOSIS;
D O I
10.3390/microorganisms11030580
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
For three years, the novel coronavirus disease 2019 (COVID-19) pandemic, caused by infection of the SARS-CoV-2 virus, has completely changed our lifestyles and prepared us to live with this novel pneumonia for years to come. Given that pre-existing flu is caused by the influenza A virus, we have begun unprecedently co-coping with two different respiratory diseases at the same time. Hence, we draw a comparison between SARS-CoV-2 and influenza A virus based on the general characteristics, especially the main variants' history and the distribution of the two viruses. SARS-CoV-2 appeared to mutate more frequently and independently of locations than the influenza A virus. Furthermore, we reviewed present clinical trials on combined management against COVID-19 and influenza in order to explore better solutions against both at the same time.
引用
收藏
页数:23
相关论文
共 50 条
  • [21] Co-infection of SARS-COV-2 and Influenza A Virus: A Case Series and Fast Review
    Xuan Xiang
    Zi-hao Wang
    Lin-lin Ye
    Xin-liang He
    Xiao-shan Wei
    Yan-ling Ma
    Hui Li
    Long Chen
    Xiao-rong Wang
    Qiong Zhou
    Current Medical Science, 2021, 41 : 51 - 57
  • [22] Co-infection of SARS-COV-2 and Influenza A Virus: A Case Series and Fast Review
    Xiang, Xuan
    Wang, Zi-hao
    Ye, Lin-lin
    He, Xin-liang
    Wei, Xiao-shan
    Ma, Yan-ling
    Li, Hui
    Chen, Long
    Wang, Xiao-rong
    Zhou, Qiong
    CURRENT MEDICAL SCIENCE, 2021, 41 (01) : 51 - 57
  • [23] SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses
    Swets, Maaike C.
    Russell, Clark D.
    Harrison, Ewen M.
    Docherty, Annemarie B.
    Lone, Nazir
    Girvan, Michelle
    Hardwick, Hayley E.
    Investigators, Isaricc
    Visser, Leonardus G.
    Openshaw, Peter J. M.
    Groeneveld, Geert H.
    Semple, Malcolm G.
    Baillie, J. Kenneth
    LANCET, 2022, 399 (10334): : 1463 - 1464
  • [24] SARS-CoV-2 and dental treatments
    Sandulescu, Mihai
    GERMS, 2020, 10 (02): : 72 - 73
  • [25] SARS-CoV-2 Virus
    Sharma, Vandana
    CLINICAL CHEMISTRY, 2022, 68 (11) : 1478 - 1478
  • [26] Comparative Perspective of Evolution of SARS-CoV-2 and 1918 Influenza Virus
    Shu Yuan
    Si-Cong Jiang
    Zhong-Wei Zhang
    Yu-Fan Fu
    Xin-Yue Yang
    Zi-Lin Li
    Jing Hu
    Journal of Evolutionary Biochemistry and Physiology, 2023, 59 : 2022 - 2032
  • [27] Comparison of Cell Fusions Induced by Influenza Virus and SARS-CoV-2
    Zhang, Chuyuan
    Meng, Xinjie
    Zhao, Hanjun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [28] A case series of coinfection with SARS-CoV-2 and influenza virus in Louisiana
    Miatech, Jennifer L.
    Tarte, Nikhil N.
    Katragadda, Silpita
    Polman, Jeremy
    Robichaux, Sarah B.
    RESPIRATORY MEDICINE CASE REPORTS, 2020, 31
  • [29] Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity
    Hagit Achdout
    Einat. B. Vitner
    Boaz Politi
    Sharon Melamed
    Yfat Yahalom-Ronen
    Hadas Tamir
    Noam Erez
    Roy Avraham
    Shay Weiss
    Lilach Cherry
    Erez Bar-Haim
    Efi Makdasi
    David Gur
    Moshe Aftalion
    Theodor Chitlaru
    Yaron Vagima
    Nir Paran
    Tomer Israely
    Nature Communications, 12
  • [30] Disease of influenza virus and SARS-CoV-2 coinfection: Flurona or Flucovid?
    Liu, Shuwen
    Li, Weihua
    Jiang, Shibo
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (09) : 4056 - 4057